A cross sectional study to assess tobacco use and its correlates among patients attending non-communicable disease clinics of a Northern Jurisdiction in India.
Clinics
India
NCDs
prevalence
smokeless
smoking
tobacco
Journal
Journal of family medicine and primary care
ISSN: 2249-4863
Titre abrégé: J Family Med Prim Care
Pays: India
ID NLM: 101610082
Informations de publication
Date de publication:
Aug 2021
Aug 2021
Historique:
received:
16
12
2020
revised:
21
02
2021
accepted:
09
04
2021
entrez:
18
10
2021
pubmed:
19
10
2021
medline:
19
10
2021
Statut:
ppublish
Résumé
Non-Communicable Diseases (NCDs) continue to rise unabated globally and the existing evidence has unequivocally established the relationship between tobacco use and NCDs. In 2010 the Government of India (GOI) introduced NCD clinics under the National Program for Prevention and Control of Cancer, Diabetes, Cardio Vascular Diseases and Stroke (NPCDCS) with the purpose of preventing and combating the NCD epidemic. This study was undertaken with an objective to comprehensively determine tobacco use and its correlates among patients attending these NCD clinics. A descriptive cross-sectional study was carried out among 1172 patients attending NCD clinics at district level, in Punjab, India between May to October 2018. Using systematic sampling every fourth patient was interviewed and equal numbers of visits were made to both the clinics. Overall, the current tobacco use in any form was reported to be 10.2% among the study respondents. Majority of the tobacco users were males (23.3%), in 40-49 year age group, (18.7%), residing in urban area (15%), educated up to secondary school (18%) and non-government occupation bracket (27.4%) and hypertension disease category (41.6%). More SLT users had thought of quitting in past in comparison to smokers (46.6% vs 40%) and had higher quit attempts in past (42.5% vs 38.3%). In the binary logistic regression analysis, odds of tobacco use increased with increasing age, three times higher among participants who were employed (OR 3.75; CI 1.41-10.02),6 times higher in COPD disease category (OR 6.88; CI 2.1-20.59). Higher tobacco use among the NCD clinic attendees with increasing age predisposes them to develop grave complications. This calls for the need to administer intensive behaviour change interventions for tobacco cessation at the existing NCD clinics. This could further strengthen existing health systems and thereby improving health outcomes followed by achieving Sustainable Development Goals.
Sections du résumé
BACKGROUND
BACKGROUND
Non-Communicable Diseases (NCDs) continue to rise unabated globally and the existing evidence has unequivocally established the relationship between tobacco use and NCDs. In 2010 the Government of India (GOI) introduced NCD clinics under the National Program for Prevention and Control of Cancer, Diabetes, Cardio Vascular Diseases and Stroke (NPCDCS) with the purpose of preventing and combating the NCD epidemic. This study was undertaken with an objective to comprehensively determine tobacco use and its correlates among patients attending these NCD clinics.
METHODS
METHODS
A descriptive cross-sectional study was carried out among 1172 patients attending NCD clinics at district level, in Punjab, India between May to October 2018. Using systematic sampling every fourth patient was interviewed and equal numbers of visits were made to both the clinics.
RESULTS
RESULTS
Overall, the current tobacco use in any form was reported to be 10.2% among the study respondents. Majority of the tobacco users were males (23.3%), in 40-49 year age group, (18.7%), residing in urban area (15%), educated up to secondary school (18%) and non-government occupation bracket (27.4%) and hypertension disease category (41.6%). More SLT users had thought of quitting in past in comparison to smokers (46.6% vs 40%) and had higher quit attempts in past (42.5% vs 38.3%). In the binary logistic regression analysis, odds of tobacco use increased with increasing age, three times higher among participants who were employed (OR 3.75; CI 1.41-10.02),6 times higher in COPD disease category (OR 6.88; CI 2.1-20.59).
CONCLUSION
CONCLUSIONS
Higher tobacco use among the NCD clinic attendees with increasing age predisposes them to develop grave complications. This calls for the need to administer intensive behaviour change interventions for tobacco cessation at the existing NCD clinics. This could further strengthen existing health systems and thereby improving health outcomes followed by achieving Sustainable Development Goals.
Identifiants
pubmed: 34660424
doi: 10.4103/jfmpc.jfmpc_2471_20
pii: JFMPC-10-2915
pmc: PMC8483119
doi:
Types de publication
Journal Article
Langues
eng
Pagination
2915-2922Informations de copyright
Copyright: © 2021 Journal of Family Medicine and Primary Care.
Déclaration de conflit d'intérêts
There are no conflicts of interest.
Références
Addict Health. 2019 Jan;11(1):35-42
pubmed: 31308908
Addict Behav. 2019 Apr;91:171-174
pubmed: 30501991
PLoS One. 2011;6(5):e20331
pubmed: 21655299
PLoS One. 2016 Jul 07;11(7):e0157705
pubmed: 27389020
Tob Control. 2006 Jun;15 Suppl 3:iii71-5
pubmed: 16754950
BMJ Open. 2018 Jun 30;8(6):e020160
pubmed: 29961006
Bull World Health Organ. 2016 Mar 1;94(3):215-21
pubmed: 26966333
Indian J Psychol Med. 2013 Apr;35(2):121-6
pubmed: 24049221
Diabetes Care. 2004 Jan;27 Suppl 1:S74-5
pubmed: 14693932
J Epidemiol. 2020 Mar 5;30(3):136-142
pubmed: 30828035
Am J Public Health. 1996 Nov;86(11):1582-9
pubmed: 8916524
Diabetol Metab Syndr. 2019 Oct 24;11:85
pubmed: 31666811
Biomed Res Int. 2016;2016:5856740
pubmed: 27127788
Front Public Health. 2020 Jun 11;8:177
pubmed: 32596196
Sci Rep. 2019 Jan 24;9(1):588
pubmed: 30679752
Arch Intern Med. 2004 Sep 27;164(17):1845-9
pubmed: 15451758
Tob Control. 2003 Dec;12(4):e4
pubmed: 14660785
Indian J Community Med. 2010 Apr;35(2):245-51
pubmed: 20922100
J Res Health Sci. 2014 Autumn;14(4):258-63
pubmed: 25503279
Nicotine Tob Res. 2011 Jan;13(1):34-40
pubmed: 21097514
Natl Med J India. 2011 Sep-Oct;24(5):280-7
pubmed: 22680079
Tob Induc Dis. 2018 May 22;16:22
pubmed: 31516422
Diabetes Res Clin Pract. 2019 Aug;154:52-65
pubmed: 31202865
Indian J Community Med. 2016 Oct-Dec;41(4):280-287
pubmed: 27890978
PLoS One. 2019 Oct 7;14(10):e0212601
pubmed: 31589619
Med Sci Monit. 2014 Jan 30;20:153-62
pubmed: 24487778
J Clin Nurs. 2011 Mar;20(5-6):819-27
pubmed: 20738455
PLoS One. 2014 Dec 04;9(12):e114073
pubmed: 25474196